Results 211 to 220 of about 22,325,925 (249)

Effectiveness of seasonal mRNA COVID-19 vaccination against post COVID-19 condition between July 2023 and September 2024 among adults aged ≥ 60 years in Germany: a population-based cohort study. [PDF]

BMC Infect Dis
Perumal N, Peine C, Steffen A, Wichmann O, Harder T.   +4 more
europepmc   +1 more source

Analysis of minimum inhibitory concentrations of azithromycin, ceftriaxone and ciprofloxacin for <i>Neisseria gonorrhoeae</i> from antimicrobial resistance sentinel surveillance, Germany, 2014 to 2023. [PDF]

Euro Surveill
Böff L, Klaper K, Dörre A, Pantke A, Buder S, Dudareva S, Bremer V, Heuer D, Jansen K, Selb R, Go-Surv-AMR study group.   +10 more
europepmc   +1 more source

Robert-Koch-Institut und Open Access

Archivalia, 2011
openaire   +1 more source

Screening the MMV Pathogen Box reveals the mitochondrial <i>bc</i>₁-complex as a drug target in mature <i>Toxoplasma gondii</i> bradyzoites. [PDF]

Elife
Maus D, Putrianti E, Hoffmann T, Laue M, Seeber F, Blume M.   +5 more
europepmc   +1 more source

Das Robert Koch-Institut im Überblick

, 2017
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Robert Koch Institut: towards digital epidemiology

Lancet, The, 2017
exaly   +3 more sources

Tuberculosis research at the Robert Koch institute

British Journal of Tuberculosis, 1932
exaly   +2 more sources

Vorwort Robert Koch-Institut

2018
Das Robert Koch-Institut hat als Public Health-Institut die Aufgabe, den Gesundheitszustand und das Gesundheitsverhalten der in Deutschland lebenden Bevolkerung zu beobachten, Trends bzw. Trendwenden festzustellen und diese Erkenntnisse adressatengerecht zu kommunizieren.
Bärbel-Maria Kurth, Patrick Schmich
openaire   +1 more source

Das Robert‐Koch‐Institut informiert

Pharmazie in unserer Zeit, 1997
  +7 more sources

Das Robert‐Koch‐Institut informiert

Pharmazie in unserer Zeit, 1995
  +7 more sources